Mapping and comparing COPD Care Pathways across 10 countries to understand barriers to optimal care: clinicians’ perspectives
![](https://aquariusph.com/app/uploads/2022/05/copd_poster_770x225-1.png)
Care Pathway Mapping for Dravet Syndrome (DS) Patients in England
![](https://aquariusph.com/app/uploads/2021/11/ispor-fin-pub-770-1.png)
Analysing the COPD care pathway in Japan, Canada, England, and Germany: a global view
![](https://aquariusph.com/app/uploads/2021/09/ERS-poster-web-pic_3.jpg)
A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting
![](https://aquariusph.com/app/uploads/2021/07/ispor-fince-pub-770.jpg)
Determining the Relationship of Seizures, Seizure Free Days and Other Predictors of Health Related Quality of Life in Patients with Dravet Syndrome (DS) and Their Carers
![](https://aquariusph.com/app/uploads/2021/07/ispor-fin-pub-770.png)
Evaluating the benefits and costs of using an mRNA versus DNA HR-HPV assay in the National Cervical Screening Programme in the Netherlands
![](https://aquariusph.com/app/uploads/2021/07/NL_770.jpg)
Modelling the impact of using a DNA compared to mRNA HPV assay as part of the cervical screening programmes in Sweden and Denmark
![](https://aquariusph.com/app/uploads/2021/07/Nordic_770.jpg)
Estimating the costs and benefits of HR-HPV assay choice in a theoretical HPV primary cervical screening algorithm in Ontario, Canada
![](https://aquariusph.com/app/uploads/2021/07/toronto-770.jpg)
Evaluating the choice of HPV assay in the French cervical screening programme with a decision tree model
![](https://aquariusph.com/app/uploads/2021/07/france_770.jpg)
Exploring HCV eradication through diagnosis and treatment strategies
![Eradicating HCV](https://aquariusph.com/app/uploads/2018/01/publication_HCV_770x225.jpg)